Upgrade to SI Premium - Free Trial

Zymeworks (ZYME)

26.91 +1.37 (5.36%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/9/26)

Latest Headlines

Zymeworks names Suzanne Monahan as SVP Commercial for YUPELRI October 19, 2026 6:00 AM - StreetInsider Zymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma October 19, 2026 6:00 AM - StreetInsider Form PRE 14A Zymeworks Inc. For: Dec 15 October 16, 2026 4:16 PM - SEC Filing Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results October 15, 2026 6:00 AM - StreetInsider Form 4 Zymeworks Inc. For: Oct 09 Filed by: Schayowitz Adam October 9, 2026 6:28 PM - SEC Filing Form 144 Zymeworks Inc. Filed by: Schayowitz Adam October 9, 2026 11:17 AM - SEC Filing Zymeworks (ZYME) PT Raised to $34 at Truist Securities October 7, 2026 7:14 AM - StreetInsider TD Cowen Reinstates Zymeworks (ZYME) at Buy September 29, 2026 9:34 AM - StreetInsider Zymeworks (ZYME) Reiterated at Market Outperform by Citizens as Theravance Biopharma Acquisition Closed September 29, 2026 5:28 AM - StreetInsider Zymeworks raises 2026 guidance after closing Theravance acquisition September 28, 2026 6:01 AM - StreetInsider Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition September 28, 2026 6:00 AM - StreetInsider Form 8-K Zymeworks Inc. For: Sep 23 September 23, 2026 4:07 PM - SEC Filing Zymeworks completes acquisition of Theravance Biopharma September 23, 2026 4:01 PM - StreetInsider Zymeworks Completes Acquisition of Theravance Biopharma September 23, 2026 4:01 PM - StreetInsider Wolfe Research Starts Zymeworks (ZYME) at Outperform September 17, 2026 5:03 AM - StreetInsider Zymeworks (ZYME) PT Raised to $33 at JPMorgan September 3, 2026 8:32 AM - StreetInsider Zymeworks (ZYME) PT Raised to $55 at H.C. Wainwright August 26, 2026 6:41 AM - StreetInsider Zymeworks (ZYME) Reiterated at Market Outperform by Citizens on FDA Approval for Zani August 26, 2026 4:21 AM - StreetInsider Zymeworks (ZYME) PT Raised to $38 at Citi August 25, 2026 4:02 PM - StreetInsider Form 8-K Zymeworks Inc. For: Aug 25 August 25, 2026 10:54 AM - SEC Filing Zymeworks Announces Participation in Upcoming Investor Conferences August 11, 2026 6:00 AM - StreetInsider Zymeworks (ZYME) PT Raised to $44 at B.Riley August 10, 2026 8:18 AM - StreetInsider Zymeworks (ZYME) PT Lowered to $46 at Stifel August 7, 2026 10:29 AM - StreetInsider Zymeworks (ZYME) PT Raised to $40 at Wells Fargo August 7, 2026 8:23 AM - StreetInsider Zymeworks (ZYME) Misses Q2 EPS by 25c August 6, 2026 5:35 PM - StreetInsider Form 10-Q Zymeworks Inc. For: Jun 30 August 6, 2026 4:16 PM - SEC Filing Form 8-K Zymeworks Inc. For: Aug 06 August 6, 2026 4:13 PM - SEC Filing Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results August 6, 2026 4:06 PM - Globe NewsWire Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results August 6, 2026 4:05 PM - StreetInsider Zymeworks (ZYME) PT Raised to $51 at H.C. Wainwright August 6, 2026 6:55 AM - StreetInsider Full Article List